What’s New at Natureza: Company & Antibiotic Industry News, Studies & Articles
What’s New at Natureza: Company & Antibiotic Industry News, Studies & Articles
Informing New Perspectives in Antimicrobial Development
Natureza® conducts research focused on the development of novel antimicrobial formulation strategies intended to address persistent challenges associated with resistant organisms. The Company has evaluated multiple antimicrobial candidates designed to support new approaches to microbial control in settings where conventional treatments face limitations. [read more]
Natureza Patents Novel Antimicrobial Formulations
Natureza’s research offers a true paradigm shift, one that would remove the imbalance in development cost by eliminating the ability of bacteria to become resistant. With the promise of new drugs being able to be marketed for years providing not only the time to recover investment, but a profit as well, a new investment environment would emerge that would encourage the development of new, much needed antibiotics. [read more]
WHO to World: The Foundation of Modern Medicine is Crumbling
The WHO has recognised a number of antibiotic-resistant pathogens as posing the greatest threat to biological systems / future human-use research. It further concluded that mortality and morbidity from resistant infections is on the rise globally, the clinical anti-bacterial pipeline remains insufficient, and the pipeline outlook remains bleak (WHO 2019). [read more]
Discover The Future
We are a multidisciplinary research laboratory focused on advancing antimicrobial formulation science through targeted discovery and applied research.